Yüklüyor......
Tumor-specific delivery of gemcitabine with activatable liposomes
Gemcitabine delivery to pancreatic ductal adenocarcinoma is limited by poor pharmacokinetics, dense fibrosis and hypo-vascularization. Activatable liposomes, with drug release resulting from local heating, enhance serum stability and circulation, and the released drug retains the ability to diffuse...
Kaydedildi:
| Yayımlandı: | J Control Release |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6815719/ https://ncbi.nlm.nih.gov/pubmed/31301340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.07.014 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|